C

Charles River Laboratories International
D

CRL

149.490
USD
-2.39
(-1.57%)
مغلق
حجم التداول
27,774
الربح لكل سهم
9
العائد الربحي
-
P/E
-245
حجم السوق
7,342,307,787
أصول ذات صلة
NEOUSD
NEOUSD
-0.08249
(-1.46%)
5.53839 USD
ABT
ABT
-0.770
(-0.56%)
135.620 USD
BDX
BDX
-2.215
(-1.27%)
172.245 USD
B
BIO
-5.265
(-2.27%)
227.145 USD
DGX
DGX
1.130
(0.63%)
180.170 USD
DHR
DHR
-4.400
(-2.15%)
200.680 USD
ILMN
ILMN
-1.120
(-1.27%)
87.000 USD
MTD
MTD
-33.18
(-2.79%)
1,155.03 USD
N
NEO
-0.33000
(-4.47%)
7.05000 USD
P
PRGO
-0.590
(-2.17%)
26.640 USD
TMO
TMO
-12.61
(-3.04%)
402.69 USD
المزيد
الأخبار المقالات

العنوان: Charles River Laboratories International

القطاع: Healthcare
الصناعة: Diagnostics & Research
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.